These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3018486)

  • 21. Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells.
    Waggoner S; Sarnow P
    J Virol; 1998 Aug; 72(8):6699-709. PubMed ID: 9658117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.
    Shiroki K; Ishii T; Aoki T; Kobashi M; Ohka S; Nomoto A
    J Virol; 1995 Nov; 69(11):6825-32. PubMed ID: 7474095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage of p220 by purified poliovirus 2A(pro) in cell-free systems: effects on translation of capped and uncapped mRNAs.
    Novoa I; Martínez-Abarca F; Fortes P; Ortín J; Carrasco L
    Biochemistry; 1997 Jun; 36(25):7802-9. PubMed ID: 9201923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression.
    Stacy T; Chamberlain M; Cole CN
    J Virol; 1989 Dec; 63(12):5208-15. PubMed ID: 2555552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region.
    Pelletier J; Kaplan G; Racaniello VR; Sonenberg N
    Mol Cell Biol; 1988 Mar; 8(3):1103-12. PubMed ID: 2835660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg.
    Reuer Q; Kuhn RJ; Wimmer E
    J Virol; 1990 Jun; 64(6):2967-75. PubMed ID: 2159557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
    Kirkegaard K; Nelsen B
    J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus RNA polymerase mutation 3D-M394T results in a temperature-sensitive defect in RNA synthesis.
    Barton DJ; Morasco BJ; Eisner-Smerage L; Collis PS; Diamond SE; Hewlett MJ; Merchant MA; O'Donnell BJ; Flanegan JB
    Virology; 1996 Mar; 217(2):459-69. PubMed ID: 8610437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in cap-binding complexes from uninfected and poliovirus-infected HeLa cells.
    Etchison D; Smith K
    J Biol Chem; 1990 May; 265(13):7492-500. PubMed ID: 2159001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection.
    Dodd DA; Giddings TH; Kirkegaard K
    J Virol; 2001 Sep; 75(17):8158-65. PubMed ID: 11483761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli.
    Alvey JC; Wyckoff EE; Yu SF; Lloyd R; Ehrenfeld E
    J Virol; 1991 Nov; 65(11):6077-83. PubMed ID: 1656087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.
    Pal-Ghosh R; Morrow CD
    J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimum internal ribosome entry site required for poliovirus infectivity.
    Haller AA; Nguyen JH; Semler BL
    J Virol; 1993 Dec; 67(12):7461-71. PubMed ID: 8230467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular RNA is not degraded in interferon-treated HeLa cells after poliovirus infection.
    Muñoz A; Harvey R; Carrasco L
    FEBS Lett; 1983 Aug; 160(1-2):87-92. PubMed ID: 6309570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis.
    Barton DJ; O'Donnell BJ; Flanegan JB
    EMBO J; 2001 Mar; 20(6):1439-48. PubMed ID: 11250909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus.
    Johnson KL; Sarnow P
    J Virol; 1991 Aug; 65(8):4341-9. PubMed ID: 1649334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translation of capped viral mRNAs in poliovirus-infected HeLa cells.
    Alonso MA; Carrasco L
    EMBO J; 1982; 1(8):913-7. PubMed ID: 6329715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
    Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
    J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural difference between the 5' termini of viral and cellular mRNA in poliovirus-infected cells: possible basis for the inhibition of host protein synthesis.
    Fernandez-Munoz R; Darnell JE
    J Virol; 1976 May; 18(2):719-26. PubMed ID: 178904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terminal 7-methyl-guanosine cap structure on the normally uncapped 5' noncoding region of poliovirus mRNA inhibits its translation in mammalian cells.
    Hambidge SJ; Sarnow P
    J Virol; 1991 Nov; 65(11):6312-5. PubMed ID: 1656097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.